title: Asymptomatic pulmonary hypertension in systemic lupus erythematosus.
abstract: BACKGROUND
  Pulmonary arterial hypertension (PAH) is a serious and often fatal complication of systemic lupus erythematosus (SLE). Because the diagnosis of PAH often is made years after symptom onset, early diagnostic strategies are essential. Doppler echocardiography currently is considered the noninvasive screening test of choice for evaluating pulmonary hypertension.
  
  
  OBJECTIVE
  Screening for asymptomatic pulmonary hypertension in systemic lupus erythematosus patients using Doppler echocardiography, and correlating it with inflammatory parameters of the disease.
  
  
  METHODS
  Doppler echocardiography was performed in 74 patients with systemic lupus erythematosus over one year (66 adult and 8 juvenile), adult SLE included 57 patients with adult-onset and 9 patients with childhood-onset. Pulmonary hypertension was diagnosed if the peak systolic pressure gradient at the tricuspid valve was more than 30 mmHg. All patients were subjected to full history taking, rheumatological examination, laboratory studies and chest x-ray.
  
  
  RESULTS
  In seventy four SLE patients, the pulmonary hypertension was detected in 8 patients (10.8%), 7 adult-onset SLE patients (aged from 19 to 30 years) and 1 juvenile SLE (aged 12 years). The range of pulmonary artery systolic pressure was 34-61.2 mmHg (43.19 ± 9.28). No significant differences between patients with and those without pulmonary hypertension as regard clinical features. Significantly higher frequencies of rheumatoid factor and anti-cardiolipin antibodies were found in patients with pulmonary hypertension versus those without (P = 0.02, P = 0.008 respectively). Positive rheumatoid factor and ACL were significantly associated with occurrence of PAH in SLE (P = 0.007, P = 0.006 respectively). No significant correlations were found between pulmonary artery pressure, disease duration, SLE Disease Activity Index (SLEDAI), ESR, and anti-ds DNA.
  
  
  CONCLUSIONS
  Patients with SLE have an increased risk of pulmonary arterial hypertension. Echocardiography should be used as a screening tool in patients at high risk for development of pulmonary hypertension. Positive anti-cardiolipin antibodies and rheumatoid factor were significant predictors of pulmonary hypertension in our study.
authors.affiliation: Department of Rheumatology and Rehabilitation, Minia University, Egypt.
authors.forename: Shereen R
authors.initials: SR
authors.lastname: Kamel
authors.forename: Gihan M
authors.initials: GM
authors.lastname: Omar
authors.forename: Ayman F
authors.initials: AF
authors.lastname: Darwish
authors.forename: Hany T
authors.initials: HT
authors.lastname: Asklany
authors.forename: Abdou S
authors.initials: AS
authors.lastname: Ellabban
references.citation: Rheumatology (Oxford). 2004 May;43(5):587-91
references.pmid: 14734790
references.citation: Chest. 2004 Jul;126(1 Suppl):14S-34S
references.pmid: 15249493
references.citation: Bull Acad Natl Med. 2004;188(6):985-97; discussion 997
references.pmid: 15651427
references.citation: Arthritis Rheum. 1992 Jun;35(6):630-40
references.pmid: 1599520
references.citation: Semin Arthritis Rheum. 1981 Aug;11(1):177-81
references.pmid: 7025213
references.citation: Rheumatology (Oxford). 2009 Dec;48(12):1506-11
references.pmid: 19671698
references.citation: Lancet. 2001 Oct 6;358(9288):1119-23
references.pmid: 11597664
references.citation: J Heart Lung Transplant. 2007 Sep;26(9):927-34
references.pmid: 17845932
references.citation: J Med Assoc Thai. 1977 Dec;60(12):670-5
references.pmid: 604410
references.citation: Br Med J (Clin Res Ed). 1983 Oct 8;287(6398):1024-5
references.pmid: 6412935
references.citation: J Am Coll Cardiol. 1985 Oct;6(4):750-6
references.pmid: 4031289
references.citation: Chest. 2000 Jan;117(1):14-8
references.pmid: 10631192
references.citation: Arq Bras Cardiol. 2000 Jan;74(1):55-71
references.pmid: 10904521
references.citation: N Engl J Med. 1973 May 17;288(20):1078-9
references.pmid: 4696623
references.citation: J Chin Med Assoc. 2004 May;67(5):248-51
references.pmid: 15357113
references.citation: Thorax. 1999 Mar;54(3):273-7
references.pmid: 10325906
references.citation: J Rheumatol. 1990 Oct;17(10):1292-8
references.pmid: 2123932
references.citation: J Rheumatol. 1989 Jul;16(7):918-25
references.pmid: 2769664
references.citation: Med Clin North Am. 1997 Jan;81(1):113-28
references.pmid: 9012757
references.citation: Am Heart J. 1995 Mar;129(3):510-5
references.pmid: 7872181
references.citation: Medicine (Baltimore). 1997 May;76(3):192-202
references.pmid: 9193454
references.citation: Chest. 2008 Jan;133(1):271-80
references.pmid: 18187752
references.citation: Johns Hopkins Med J. 1981 Feb;148(2):78-80
references.pmid: 7206403
references.citation: Clin Exp Rheumatol. 2010 Nov-Dec;28(6):836-41
references.pmid: 21205461
references.citation: Hum Pathol. 1991 Mar;22(3):295-7
references.pmid: 2004751
references.citation: Arthritis Rheum. 1982 Nov;25(11):1271-7
references.pmid: 7138600
references.citation: Circulation. 1984 Oct;70(4):657-62
references.pmid: 6478568
references.citation: Rheumatol Int. 2012 Jun;32(6):1727-31
references.pmid: 21437686
references.citation: J Microbiol Immunol Infect. 2007 Dec;40(6):525-31
references.pmid: 18087634